Deutsch English Français

Contact

EP2462952

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2462952

EP2462952 - Cancer gene therapy using nucleic acids encoding US28 [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 24.05.2013 Database last updated on 02.11.2024
Most recent event Tooltip	24.05.2013	Application deemed to be withdrawn	published on 26.06.2013 [2013/26]
Applicant(s)	For all designated states Medizinische Universität Graz Auenbruggerplatz 2 8036 Graz / AT
	[2012/52]
Former [2012/24]	For all designated states Medizinische Universität Graz Universitätsplatz 3 8010 Graz / AT
Inventor(s)	01 / Schaider, Helmut Eißlgasse 47 8010, Graz / AT
	02 / Joshi, Shripad Am Rehgrund 4/13 8043, Graz / AT
	[2012/24]
Representative(s)	Bühler, Dirk Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE
	[N/P]
Former [2012/24]	Bühler, Dirk Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3 80335 München / DE
Application number, filing date	10194621.8	10.12.2010
	[2012/24]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2462952
	Date:	13.06.2012
	Language:	EN
	[2012/24]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	03.05.2011
Classification	IPC:	A61K48/00, A61K38/16	[2012/24]
	CPC:	C07K14/4722 (EP,US); A61K31/711 (EP,US); A61K38/177 (EP,US); A61K45/06 (US); A61K48/00 (US); A61K48/005 (EP,US); (+) A61P35/00 (EP); C07K14/005 (US); C07K2319/00 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/24]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	Krebsgentherapie unter Verwendung von US28-codierenden Nukleinsäuren	[2012/24]
	English:	Cancer gene therapy using nucleic acids encoding US28	[2012/24]
	French:	Thérapie génique du cancer utilisant des acides nucléiques codant US28	[2012/24]
Examination procedure	14.12.2012	Application deemed to be withdrawn, date of legal effect [2013/26]
	21.01.2013	Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2013/26]
Fees paid	Penalty fee
	Additional fee for renewal fee
	31.12.2012	03 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X] - Joshi et al, "Abstract 4350: ANTI-PROLIFERATIVE AND APOPTOTIC EFFECTS OF HCMV US28 IN MELANOMA CELS", (20090418), 100th AACR Annual Meeting, URL: http://www.aacrmeetingabstracts.org/cgi/content/meeting_abstract/2009/2_Annual_Meeting/4350?maxtoshow=&hits=10&RESULTFORMAT=&author1=joshi&fulltext=us28&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT, (20110413), XP002632795 [X] 1-16 * the whole document *
		[X] - SCHAIDER ET AL, "A SIGNALING MUTE HCMV CHEMOKINE RECEPTOR PREVENTS MELANOMA GROWTH", (20070414), 98TH AACR ANNUAL MEETING, URL: http://www.aacrmeetingabstracts.org/cgi/content/meeting_abstract/2007/1_Annual_Meeting/2521?maxtoshow=&hits=10&RESULTFORMAT=&author1=schaider&fulltext=melanoma&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT, (20110413), XP002632796 [X] 1-16 * the whole document *
		[X] - MOSER ELISABETH ET AL, "The hCMV chemokine receptor US28 prevents melanoma growth", BMC PHARMACOLOGY, BIOMED CENTRAL, LONDON, GB, (20071114), vol. 7, no. Suppl 2, doi:10.1186/1471-2210-7-S2-A4, ISSN 1471-2210, page A4, XP021028694 [X] 1-16 * the whole document * DOI: http://dx.doi.org/10.1186/1471-2210-7-S2-A4
		[X] - MOSER ELISABETH ET AL, "US28 in melanoma growth", BMC PHARMACOLOGY, BIOMED CENTRAL, LONDON, GB, (20081105), vol. 8, no. Suppl 1, doi:10.1186/1471-2210-8-S1-A2, ISSN 1471-2210, page A2, XP021042532 [X] 1-16 * the whole document * DOI: http://dx.doi.org/10.1186/1471-2210-8-S1-A2
		[X] - MOSER, "THE INTERACTION OF THE HUMAN CYTOMEGALOVIRUS ENCODED CHEMOKINE RECEPTOR US28 AND GASP-1 AND ITS IMPLICATION ON RECEPTOR TRAFFICKING AND MELANOMA GROWTH.", (20100729), page 157PP, Dissertation (Ph.D.), Medical University of Graz, URL: https://online.medunigraz.at/mug_online/wbabs.getDocument?pThesisNr=18190&pAutorNr=&pOrgNr=1, (20110413), XP002632797 [X] 1-16 * page 58 - page 72 *
		[ ] - (20100729), URL: http://www.meduni-graz.at/images/content/file/studium/phd/pdf/Ausschr-PhD-29072010.pdf
		[A] - ANONYMOUS, "14th Symposium of the Austrian-Pharmacological-Society, Innsburck, AUSTRIA, November 21 -22, 2008", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200811), Database accession no. PREV200900059127, XP002632798 [A] 1 * abstract *
		[A] - ANONYMOUS, "15th Symposium of the Austrian-Pharmacological-Society, Graz, AUSTRIA, November 19 -21, 2009", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200911), Database accession no. PREV201000048334, XP002632799 [A] 1 * abstract *
		[A] - ANONYMOUS, "Joint Meeting of the 13th Symposium of the Austrian-Pharmacological-S ociety/Austrian-Society-of-Toxicology/Hungarian-Society-for-Experimen tal-and-Clinical-Pharmacology, Vienna, AUSTRIA, November 22 -24, 2007", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2007), Database accession no. PREV200800570113, XP002632800 [A] 1 * abstract *
	by applicant	WO0011950
		WO0217900
		US2008020994
		US6344436
		US6514947
		US6670177
		US6743779
		US6806084
		US6903077
		- SAMEL ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, (2003), vol. 278, no. 34, pages 32077 - 32082
		- BERTIN ET AL., INT. J. CANCER, (1997), vol. 71, pages 1029 - 1034
		- PLESKOFF ET AL., FEBS JOURNAL, (2005), vol. 272, pages 4163 - 4177
		- Gene Therapy Protocols Vol. 1; Production and In vivo applications of Gene Transfer Vectors, Meth. Mol. Biol., HUMANA PRESS, (2008), vol. 1
		- "Antibody Engineering", Springer Protocols, SPRINGER, (2010), vol. 1, 2

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p